This proposal responds to the programmatic priorities of RFA PA 99-162 """"""""Stages of breast development: normal to metastatic disease."""""""" We propose to study the mechanism by which mammary development and involution regulate the development of breast cancer. It is our general hypothesis that programmed cell death (PCD) of mammary epithelial cells during involution is mediated by the FasIFasL system. Others and we have proposed that apoptosis associated with breast involution confers resistance to tumorigenesis while inappropriate survival of the secretory epithelial cells apparently increases susceptibility to tumor development. Accordingly, conditions that limit proliferation or cause breast epithelial cell death could result in reduction of risk for breast cancer in humans. Our data indicates that the expression of Fas receptor protein on the mammary cell surface triggers apoptosis at the end of lactation. Thus, alterations in the Fas/FasL system may regulate the survival of proliferating cells that have the potential for malignant transformation. It is our second hypothesis that breast cancer may arise from the failure of the FasIFasL apoptotic pathway that would normally eliminate aging or transformed cells that are at risk of malignant transformation. The absence of the Fasmediated-apoptotic signal results in the persistence of transformed cells expressing only FasL on their surface. To prove the validity of our hypothesis we propose a four-year plan to: 1) Study Fas and FasL expression in normal mouse mammary gland and its role in mammary gland development and remodeling. 2) Study the role of Fas and FasL in normal and pathologic mouse mammary gland development in Fas and FasL deficient mice. 3) To investigate the regulation of Fas and FasL expression and function; and 4) Study the regulation of FasL expression by estrogen and selective estrogen receptor modulators (SERMs). A thin line separates normal from neoplastic development. A delicate balance between cell growth and cell apoptosis maintains this homeostatic state. Once that line is breached the same genes protecting the organism from cancer may become involved in its genesis. The genes encoding Fas and FasL, which normally regulate homeostasis yet have the potential to foster malignant growth, exemplify' this tenuous balance. A more thorough understanding of the function and regulation of the genes involved in tissue homeostasis and tumor suppression will provide valuable information related to the biology and development of the normal mammary gland. With an improved foundation of the normal mammary physiology, we can advance the understanding of breast cancer, allowing the development of effective strategies for its treatment and prevention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA092435-03
Application #
6634094
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Macleod, Carol L
Project Start
2001-06-01
Project End
2005-05-31
Budget Start
2003-06-11
Budget End
2005-05-31
Support Year
3
Fiscal Year
2003
Total Cost
$271,410
Indirect Cost
Name
Yale University
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Kluger, Harriet M; McCarthy, Mary M; Alvero, Ayesha B et al. (2007) The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization. J Transl Med 5:6
Alvero, Ayesha B; O'Malley, David; Brown, David et al. (2006) Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer 106:599-608
Straszewski-Chavez, Shawn L; Abrahams, Vikki M; Mor, Gil (2005) The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev 26:877-97
Abrahams, Vikki M; Straszewski-Chavez, Shawn L; Guller, Seth et al. (2004) First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 10:55-63
Flick, Maryann B; O'Malley, David; Rutherford, Thomas et al. (2004) Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients. J Soc Gynecol Investig 11:252-9
Sapi, Eva; Alvero, Ayesha B; Chen, Wei et al. (2004) Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncol Res 14:567-78
Abrahams, Vikki M; Kim, Yeon Mee; Straszewski, Shawn L et al. (2004) Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol 51:275-82
Zhang, Jing-Xin; Labaree, David C; Mor, Gil et al. (2004) Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator. J Clin Endocrinol Metab 89:3527-35
Mor, Gil; Sapi, Eva; Abrahams, Vikki M et al. (2003) Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170:114-22
Chu, Micheline C; Mor, Gil; Lim, Chungyun et al. (2003) Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 90:170-6

Showing the most recent 10 out of 18 publications